Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Saved in:
| Title: | Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma. |
|---|---|
| Authors: | Kacimi SEO; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Dehais C; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Feuvret L; Hospices Civils de Lyon, Radiotherapy Department, Bron, France., Chinot O; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France., Carpentier C; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France., Bronnimann C; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France., Vauleon E; Centre Eugène Marquis, Medical Oncology, INSERM U1242, University of Rennes, Rennes, France., Djelad A; Department of Neurosurgery, University Hospital of Lille, Lille, France., Cohen-Jonathan Moyal E; Department of Radiation Oncology, Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale U1037, Centre de Recherche contre le Cancer de Toulouse, Toulouse, France.; Université Toulouse III Paul Sabatier, Toulouse, France., Langlois O; Department of Neurosurgery, University Hospital of Rouen, Rouen, France., Campone M; Institut de Cancérologie de l'Ouest-René Gauducheau, Centre de Recherche en Cancérologie, Saint Herblain, France., Ducloie M; Department of Neurology, CHU de Caen Normandie, Caen, France., Noel G; Radiation Oncology Department, Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France.; Radiobiology Laboratory, Centre Paul Strauss, IIMIS - Imagerie Multimodale Integrative en Santé, ICube, Strasbourg University, Strasbourg, France., Cuzzubbo S; Neurology Department, APHP, University Hospital Saint Louis, Paris, France.; Université Paris Cité, Paris, France., Taillandier L; Neurology Department, CHU de Nancy, Nancy, France., Ramirez C; Neurology Department, North Hospital, University Hospital of Saint Etienne, Saint-Priest-en-Jarez, France., Younan N; Neurology Department, Hôpital Foch, Suresnes, France., Menei P; Neurosurgery Department, CHU Angers, Angers, France., Dhermain F; Radiotherapy Department, Institut Gustave Roussy, Villejuif, France., Desenclos C; Neurosurgery Department, Hôpital Nord, CHU Amiens, Amiens, France., Ghiringhelli F; Centre Georges-François Leclerc, Medical Oncology, Dijon, France., Bourg V; Neurology Department, CHU Nice, Nice, France., Ricard D; Neurology department, Hôpital National d'Instruction des Armées Percy, Service de Santé des Armées, Clamart, France., Faillot T; Neurosurgery Department, AP-HP, Hôpital Beaujon, Clichy, France., Appay R; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France., Tabouret E; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France., Nichelli L; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuroradiologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Mathon B; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neurochirurgie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Thomas A; Service de Radiothérapie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Tran S; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Bielle F; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Alentorn A; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Iorgulescu JB; Molecular Diagnostics Laboratory, Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Boëlle PY; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Labreche K; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France., Hoang-Xuan K; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Sanson M; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Idbaih A; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France., Figarella-Branger D; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France., Ducray F; Neuro-Oncology Unit, Hospices Civils de Lyon, Lyon, France.; LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard, Villeurbanne, France., Touat M; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.; Department of Neurology, Brigham and Women's Hospital, Boston, MA. |
| Corporate Authors: | POLA Network |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jan 20; Vol. 43 (3), pp. 329-338. Date of Electronic Publication: 2024 Oct 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39356975 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kacimi+SEO%22">Kacimi SEO</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dehais+C%22">Dehais C</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Feuvret+L%22">Feuvret L</searchLink>; Hospices Civils de Lyon, Radiotherapy Department, Bron, France.<br /><searchLink fieldCode="AU" term="%22Chinot+O%22">Chinot O</searchLink>; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Carpentier+C%22">Carpentier C</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bronnimann+C%22">Bronnimann C</searchLink>; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Vauleon+E%22">Vauleon E</searchLink>; Centre Eugène Marquis, Medical Oncology, INSERM U1242, University of Rennes, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Djelad+A%22">Djelad A</searchLink>; Department of Neurosurgery, University Hospital of Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Cohen-Jonathan+Moyal+E%22">Cohen-Jonathan Moyal E</searchLink>; Department of Radiation Oncology, Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.; Institut National de la Santé et de la Recherche Médicale U1037, Centre de Recherche contre le Cancer de Toulouse, Toulouse, France.; Université Toulouse III Paul Sabatier, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Langlois+O%22">Langlois O</searchLink>; Department of Neurosurgery, University Hospital of Rouen, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Campone+M%22">Campone M</searchLink>; Institut de Cancérologie de l'Ouest-René Gauducheau, Centre de Recherche en Cancérologie, Saint Herblain, France.<br /><searchLink fieldCode="AU" term="%22Ducloie+M%22">Ducloie M</searchLink>; Department of Neurology, CHU de Caen Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Noel+G%22">Noel G</searchLink>; Radiation Oncology Department, Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France.; Radiobiology Laboratory, Centre Paul Strauss, IIMIS - Imagerie Multimodale Integrative en Santé, ICube, Strasbourg University, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Cuzzubbo+S%22">Cuzzubbo S</searchLink>; Neurology Department, APHP, University Hospital Saint Louis, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Taillandier+L%22">Taillandier L</searchLink>; Neurology Department, CHU de Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Ramirez+C%22">Ramirez C</searchLink>; Neurology Department, North Hospital, University Hospital of Saint Etienne, Saint-Priest-en-Jarez, France.<br /><searchLink fieldCode="AU" term="%22Younan+N%22">Younan N</searchLink>; Neurology Department, Hôpital Foch, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Menei+P%22">Menei P</searchLink>; Neurosurgery Department, CHU Angers, Angers, France.<br /><searchLink fieldCode="AU" term="%22Dhermain+F%22">Dhermain F</searchLink>; Radiotherapy Department, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Desenclos+C%22">Desenclos C</searchLink>; Neurosurgery Department, Hôpital Nord, CHU Amiens, Amiens, France.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; Centre Georges-François Leclerc, Medical Oncology, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bourg+V%22">Bourg V</searchLink>; Neurology Department, CHU Nice, Nice, France.<br /><searchLink fieldCode="AU" term="%22Ricard+D%22">Ricard D</searchLink>; Neurology department, Hôpital National d'Instruction des Armées Percy, Service de Santé des Armées, Clamart, France.<br /><searchLink fieldCode="AU" term="%22Faillot+T%22">Faillot T</searchLink>; Neurosurgery Department, AP-HP, Hôpital Beaujon, Clichy, France.<br /><searchLink fieldCode="AU" term="%22Appay+R%22">Appay R</searchLink>; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Tabouret+E%22">Tabouret E</searchLink>; Department of Neuro-Oncology, Aix-Marseille Université, CHU Timone, AP-HM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Nichelli+L%22">Nichelli L</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuroradiologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mathon+B%22">Mathon B</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neurochirurgie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Thomas+A%22">Thomas A</searchLink>; Service de Radiothérapie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tran+S%22">Tran S</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bielle+F%22">Bielle F</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuropathologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Alentorn+A%22">Alentorn A</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Iorgulescu+JB%22">Iorgulescu JB</searchLink>; Molecular Diagnostics Laboratory, Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Boëlle+PY%22">Boëlle PY</searchLink>; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Labreche+K%22">Labreche K</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Sorbonne Université, CinBioS, UMS 37 PASS, INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hoang-Xuan+K%22">Hoang-Xuan K</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sanson+M%22">Sanson M</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Idbaih+A%22">Idbaih A</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Figarella-Branger+D%22">Figarella-Branger D</searchLink>; Department of Pathology and Neuropathology, Aix-Marseille University, CHU Timone, AP-HM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Ducray+F%22">Ducray F</searchLink>; Neuro-Oncology Unit, Hospices Civils de Lyon, Lyon, France.; LabEx Dev2CAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Touat+M%22">Touat M</searchLink>; Institut du Cerveau, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne Université, AP-HP, SIRIC CURAMUS, Paris, France.; Service de Neuro-oncologie, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, AP-HP, Sorbonne Université, Paris, France.; Department of Neurology, Brigham and Women's Hospital, Boston, MA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22POLA+Network%22">POLA Network</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Jan 20; Vol. 43 (3), pp. 329-338. <i>Date of Electronic Publication: </i>2024 Oct 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39356975 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.24.00049 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 329 Titles: – TitleFull: Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kacimi SEO – PersonEntity: Name: NameFull: Dehais C – PersonEntity: Name: NameFull: Feuvret L – PersonEntity: Name: NameFull: Chinot O – PersonEntity: Name: NameFull: Carpentier C – PersonEntity: Name: NameFull: Bronnimann C – PersonEntity: Name: NameFull: Vauleon E – PersonEntity: Name: NameFull: Djelad A – PersonEntity: Name: NameFull: Cohen-Jonathan Moyal E – PersonEntity: Name: NameFull: Langlois O – PersonEntity: Name: NameFull: Campone M – PersonEntity: Name: NameFull: Ducloie M – PersonEntity: Name: NameFull: Noel G – PersonEntity: Name: NameFull: Cuzzubbo S – PersonEntity: Name: NameFull: Taillandier L – PersonEntity: Name: NameFull: Ramirez C – PersonEntity: Name: NameFull: Younan N – PersonEntity: Name: NameFull: Menei P – PersonEntity: Name: NameFull: Dhermain F – PersonEntity: Name: NameFull: Desenclos C – PersonEntity: Name: NameFull: Ghiringhelli F – PersonEntity: Name: NameFull: Bourg V – PersonEntity: Name: NameFull: Ricard D – PersonEntity: Name: NameFull: Faillot T – PersonEntity: Name: NameFull: Appay R – PersonEntity: Name: NameFull: Tabouret E – PersonEntity: Name: NameFull: Nichelli L – PersonEntity: Name: NameFull: Mathon B – PersonEntity: Name: NameFull: Thomas A – PersonEntity: Name: NameFull: Tran S – PersonEntity: Name: NameFull: Bielle F – PersonEntity: Name: NameFull: Alentorn A – PersonEntity: Name: NameFull: Iorgulescu JB – PersonEntity: Name: NameFull: Boëlle PY – PersonEntity: Name: NameFull: Labreche K – PersonEntity: Name: NameFull: Hoang-Xuan K – PersonEntity: Name: NameFull: Sanson M – PersonEntity: Name: NameFull: Idbaih A – PersonEntity: Name: NameFull: Figarella-Branger D – PersonEntity: Name: NameFull: Ducray F – PersonEntity: Name: NameFull: Touat M IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 01 Text: 2025 Jan 20 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 43 – Type: issue Value: 3 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |